Sale of Santen Pharmaceutical’s manufacturing facility

Santen Pharmaceutical

Posted on

4 Feb

2019

Share this

Fast facts

Status:

Pending

Cross-border:

Yes

Deal value:

Undisclosed

Dittmar & Indrenius > References > Sale of Santen Pharmaceutical’s manufacturing facility

We advised Santen Pharmaceutical on certain aspects of the sale of its manufacturing facility in Tampere, Finland, to NextPharma.

We advised Japanese ophthalmology specialist Santen Pharmaceutical on certain aspects of the sale of its manufacturing facility in Tampere, Finland, to NextPharma, a leading European pharmaceutical contract development and manufacturing organization (CDMO).

The transaction is expected to be completed in the summer of 2019, with NextPharma taking over production of Santen products in the facility. Santen’s 181 employees at the site, who work in manufacturing and related operations, including quality control, quality assurance, IT and administration, will transfer to NextPharma.

Related references

Share this

Dittmar & Indrenius